Penumbra (PEN): Debts to Book Capitalization

Graphic logo of Penumbra (PEN)

Penumbra, Inc. (PEN) creates a critical environment for saving lives during thrombosis by deeply integrating its systems into surgical protocols. Dominance in vascular medicine is driven by the implementation of innovative AI catheters. Production stability is maintained through strict control of material supply chains. On GURU.Markets, the leverage-to-market capitalization ratio clearly demonstrates the capital structure, where the 0.13 indicator expresses the state of the metric.

Penumbra Medical (PEN) Debts to Book Capitalization Ratio: for the period 07/04/2022 - 10/28/2026
Product sample of Penumbra Medical

For Penumbra, Inc. (PEN), this indicator measures the proportion of debt obligations within the equity structure, allowing for an assessment of the business's financial autonomy while developing costly thrombus aspiration systems. Analyzing the ratio of borrowed funds to capitalization helps balance default risk against leverage efficiency, confirming that the high margins of medical devices ensure the company's stability.

Competitors of Penumbra, Inc.

Debt to Book Capitalization Ratio DexCom, Inc.|Debt to Net Assets Ratio novanta.com NOVT|Haemonetics - Debts to Book Capitalization|INSP: Debts to Book Capitalization|Debt to Book Capitalization Ratio PROCEPT BioRobotics Inc (PRCT)|CONMED Inc. (CNMD) - Debts to Book Capitalization Ratio|Debts to Book Capitalization PLSE (Pulse Biosciences, Inc.)|Debts to Book Value inmodemd.com (INMD)|Debt to Book Value PMI|Debts to Book Capitalization Surmodics Inc SRDX|Debt to Book Value senseonics.com (SENS)|Debt to Book Capital NeuroPace Medical NPCE|Debts to Book Capitalization TCMD (Tactile Systems Technology Inc.)|SNWV - Debts to Net Assets|OM (Outset Medical) - Debts to Book Capitalization|Debt to Book Value Electromed|LNSR - Debt to Book Value|Debt to Net Assets Ratio RCEL|Debt to Book Capitalization Ratio PROF (Profound Medical Corp.)|Debt to Book Value bairdmed.com (BDMD)|EDAP: Debts to Book Capitalization|Debts to Book Value Apyx Medical Corp APYX|IceCure Medical, Ltd. (ICCM) - Debts to Book Capitalization|LUNG - Debt to Book Value Ratio|telabio.com - Debts to Book Capitalization|CytoSorbents Corporation (CTSO) - Debts to Net Assets|Debts to Book Capitalization SRTS|Debt to Book Value Zynex Medical|Debts to Book Capitalization ECOR|Debts to Book Capitalization RBOT (vicarioussurgical.com)|Debt to Book Capitalization Ratio Inspira Technologies IINN|ICU - Debt to Book Capitalization Ratio|Debt to Book Value IRIDEX Corp. (IRIX)|INBS - Debt to Net Assets Ratio|Debts to Book Capitalization XAIR|PFSA (Profusa, Inc) - Debts to Book Value|STRATA Skin Sciences Inc. - Debt to Book Capitalization Ratio|Debt to Net Assets glucotrack.com (GCTK)|Debt to Book Value NAOV|Debts to Book Capitalization Venus Concept Inc (VERO)|Debts to Book Capitalization NUWE|Aethlon Medical Corp - Debts to Net Assets|Debt to Book Capitalization Ratio TransEnterix|AVGR: Debts to Book Capitalization Ratio|BSGM (Biosig Technologies) - Debt to Book Capitalization Ratio|Cutera Inc. (CUTR) - Debt to Book Value|Debts to Book Capitalization KNW (Know Labs Corp)|Debts to Book Value NARI|Debt to Book Capitalization Ratio Nevro Corp. NVRO|Debt to Book Value Ratio reshapelifesciences.com RSLS|Debt to Book Value Silk Road Medical (SILK)